Description
NSE announces listing of 2,669,951 equity shares of Astec LifeSciences Limited allotted under Rights Issue, effective July 31, 2025.
Summary
NSE has announced the listing of 2,669,951 additional equity shares of Astec LifeSciences Limited (Symbol: ASTEC) allotted under a Rights Issue. The shares will be available for trading on the Capital Market segment from July 31, 2025, with an issue price of Rs. 890 per share.
Key Points
- 2,669,951 equity shares of Rs. 10/- face value each to be listed
- Issue price: Rs. 890 per share
- Date of allotment: July 29, 2025
- Distinctive number range: 19611711 to 22281661
- Market lot size: 1 share
- Shares are pari passu with existing equity shares
- ISIN: INE563J01010
Regulatory Changes
No regulatory changes introduced. Standard listing procedure under existing NSE Capital Market Trading Regulations.
Compliance Requirements
- Trading members must use designated security codes for identification
- Trading must be conducted in specified lot sizes
- Shares initially credited under temporary ISIN as per SEBI circulars CIR/MRD/DP/21/2012 and CIR/MRD/DP/24/2012
Important Dates
- Allotment date: July 29, 2025
- Trading commencement: July 31, 2025
- Circular effective date: July 31, 2025
Impact Assessment
The listing increases Astec LifeSciences’ total tradeable shares, potentially improving liquidity. Rights issue shareholders can now trade their allotted shares. The high issue price of Rs. 890 suggests strong investor confidence in the company’s prospects.
Impact Justification
Standard listing circular for rights issue shares - affects existing shareholders and trading liquidity